Mick Mulvaney hinted at a strategy to combat high drug prices for those insured through Medicare this week while attending a Stanford University conference. The strategy would involve drug makers paying a mandatory Medicare rebate off a drug’s list price. This would...
The Texas House of Representatives welcomed telehealth businesses to an additional 28 million state residents this week by passing a patient-access bill. The healthcare trend has cemented itself as an insurance-approved method of connecting physicians and patients via...
Bayer Pharmaceuticals announced this week that its cancer drug, Copanlisib, has been granted priority review by the FDA. The expedited process means that Bayer will know within 6 months whether Copanlisib has been granted regulatory approval versus the standard 10...
Health insurer Cigna has announced that by working with hospitals and healthcare providers through a value-based approach, its patient’s opioid use has decreased by 12%. The approach involved Cigna reporting to healthcare providers when prescription trends are not...
Pfizer has launched its mobile app and website, ATLAS, this week in an effort to help insurers, physicians, and everyday consumers track resistance rates and drug trends. The app allows users to see global resistance rates as well as pinpointed areas around the world....
